1. Home
  2. MDGL vs TPG Comparison

MDGL vs TPG Comparison

Compare MDGL & TPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$556.83

Market Cap

12.5B

Sector

Health Care

ML Signal

HOLD

Logo TPG Inc.

TPG

TPG Inc.

HOLD

Current Price

$66.63

Market Cap

8.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDGL
TPG
Founded
2011
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
12.5B
8.9B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
MDGL
TPG
Price
$556.83
$66.63
Analyst Decision
Strong Buy
Buy
Analyst Count
14
13
Target Price
$553.08
$67.00
AVG Volume (30 Days)
317.0K
1.8M
Earning Date
11-04-2025
11-04-2025
Dividend Yield
N/A
2.60%
EPS Growth
N/A
N/A
EPS
N/A
0.10
Revenue
$740,640,000.00
$4,255,344,000.00
Revenue This Year
$436.04
N/A
Revenue Next Year
$53.17
$27.41
P/E Ratio
N/A
$686.34
Revenue Growth
864.21
24.91
52 Week Low
$265.00
$37.52
52 Week High
$605.00
$70.99

Technical Indicators

Market Signals
Indicator
MDGL
TPG
Relative Strength Index (RSI) 54.32 70.70
Support Level $546.20 $57.53
Resistance Level $589.67 $69.20
Average True Range (ATR) 20.61 1.87
MACD -6.67 0.93
Stochastic Oscillator 20.49 81.63

Price Performance

Historical Comparison
MDGL
TPG

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About TPG TPG Inc.

TPG Inc is an alternative asset management firm. It invests across five multi-product platforms namely Capital, Growth, Impact, Real Estate, Market Solutions, and TPG Angelo Gordon. The company focuses on large-scale, control-oriented private equity investments.

Share on Social Networks: